Chang Chun, China Clinical Trials

A listing of Chang Chun, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

This study is designed to evaluate the efficacy and safety of eltrombopag when added to r-ATG and CsA in treatment naive East-Asian adult and pediatric patients with SAA.

Novartis Investigative Site
 (3.5 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +12 other locations
A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

This study will evaluate the efficacy and safety of CBP-307 in subjects with moderate to severe ulcerative colitis (UC).

Connect Investigative Site 2015
 (3.5 away) Contact site
  • 0 views
  • 22 May, 2021
  • +76 other locations
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.

The First Bethune Hospital of Jilin University
 (3.5 away) Contact site
  • 0 views
  • 24 May, 2021
  • +69 other locations
Evaluate the Safety Tolerability and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

The experiment is divided into two parts: Part 1 and Part 2.Part 1 was the initial treatment patient and Part 2 was the treated patient.

The first hospital of jilin university
 (2.2 away) Contact site
  • 4 views
  • 24 Jan, 2021
  • +36 other locations
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China

A Phase 2, multi center, open label, dual cohort study to evaluate the efficacy and safety of lorlatinib (PF 06463922) monotherapy in ALK inhibitor treated locally advanced or metastatic ALK positive non small cell lung cancer patients in China

neutrophil count
serum bilirubin level
kinase inhibitor
secondary malignant neoplasm of liver
lung carcinoma
Department of Oncology, Jilin Provincial Cancer Hospital
 (2.2 away) Contact site
  • 15 views
  • 11 Jun, 2021
  • +26 other locations
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

This is a study to evaluate the efficacy and safety of TQB2450 injection or combined with anlotinib hydrochloride capsule in the treatment of recurrent or metastatic advanced endometrial cancer.

The First Bethune Hospital of Jilin University
 (3.5 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +34 other locations
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

An open-label, single-arm, multi-center phase 2 study to evaluate the efficacy and safety of oral histone deacetylase (HDAC)-inhibitor abexinostat, as monotherapy in patients with relapsed or refractory follicular lymphoma (FL)

ct scan
refractory follicular lymphoma
Jilin Cancer Hospital
 (2.2 away) Contact site
  • 0 views
  • 24 May, 2021
  • +25 other locations
A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers

This is a single-arm, multicenter, phase 2 study to assess the efficacy and safety of Toripalimab Injection (JS001) in patients with advanced recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma who have failed at least 2 prior lines of therapy and are positive for specific markers. Patients who meet the …

Affiliated Tumor Hospital of Harbin Medical University
 (149.0 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +38 other locations
A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

The study is designed to study the efficacy of IV OsrHSA or positive control HSA (10 g and 20 g IV everyday) for 14 days. After a screening period of up to 14 days, the eligible subjects will be randomized in a 4:1 ratio to OsrHSA and positive control HSA, …

First Hospital of Jilin University
 (3.5 away) Contact site
  • 0 views
  • 15 Apr, 2021
  • 1 location
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Acral melanoma is a melanoma that affects acral areas of the skin, which is the most prevalent site of melanoma in non-Caucasians.Data in this subgroup is scarce.This study is to evalueate the efficiency and safety of Neoadjuvant SHR-1210 plus apatinib in this particular group,menawhile to determine the predictive value for …

The First Hospital of Jilin University
 (3.5 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • 1 location